Evidence map›Paper›PMID 37138005›Full record

ArticleScientific reports2023

Mucosal immunity in health care workers' respiratory tracts in the post-COVID-19 period.

Nadezhda Kryukova, Irina Baranova, Natalia Abramova, Ekaterina Khromova, Dmitry Pachomov, Oksana Svitich, Alexander Chuchalin, Mikhail Kostinov

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Nadezhda KryukovaPirogov Russian National Research Medical University, Moscow, Russian Federation. kryukovanadia@gmail.com.
Irina BaranovaPirogov Russian National Research Medical University, Moscow, Russian Federation.
Natalia AbramovaI. Mechnikov Research Institute of Vaccines and Sera, Moscow, Russian Federation.
Ekaterina KhromovaI. Mechnikov Research Institute of Vaccines and Sera, Moscow, Russian Federation.
Dmitry PachomovI. Mechnikov Research Institute of Vaccines and Sera, Moscow, Russian Federation.
Oksana SvitichI. Mechnikov Research Institute of Vaccines and Sera, Moscow, Russian Federation.
Alexander ChuchalinPirogov Russian National Research Medical University, Moscow, Russian Federation.
Mikhail KostinovI. Mechnikov Research Institute of Vaccines and Sera, Moscow, Russian Federation.
Research Institute of Vaccines and Sera. Mechnikov of the Russian Academy of Medical Sciences · RUPirogov Russian National Research Medical University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronavirus disease (COVID-19) has generated interest in the assessment of systemic immune status, but existing knowledge about mucosal immunity is clearly insufficient to understand the full pathogenetic mechanisms of the disease. The aim of this study was to evaluate the long-term effects of novel coronavirus infection on mucosal immunity in the postinfection period among health care workers (HCWs). A total of 180 health care workers with and without a history of COVID-19 who ranged in age from 18 to 65 years were enrolled in this one-stage, cross-sectional study. The study subjects completed the 36-Item Short Form (36) Health Survey (SF-36) and the Fatigue Assessment Scale. Secretory immunoglobulin A (sIgA) and total immunoglobulin G (IgG) levels were quantified in saliva samples, induced sputum samples, and nasopharyngeal and oropharyngeal scrapings by an enzyme-linked immunosorbent assay. Specific anti-SARS-CoV-2 IgG antibodies were quantified in serum samples by chemiluminescence immunoassay. Analysis of the questionnaire data showed that all HCWs with a history of COVID-19 reported health problems that limited their daily activities and negative changes in their emotional health three months after the disease, regardless of its severity. The following shifts were detected in the adaptive arm of the immune response in different mucosal compartments. Among subjects who had severe or moderate-to-severe COVID-19, salivary sIgA levels were significantly higher than those in the control group (p < 0.05 and p < 0.005, respectively). Compared to the subjects in the control group, all subjects with prior COVID-19 had significantly higher levels of total IgG in induced sputum. In the group of patients who had had severe infection, total IgG in saliva was also higher (p < 0.05). A direct statistically significant correlation was also detected between the levels of total IgG in all studied samples and the levels of specific IgG antibodies against SARS-CoV-2 in the serum. A significant correlation was observed between total IgG levels and the parameters of physical and social activities, mental health, and fatigue levels. Our study demonstrated long-term changes in the humoral mucosal immune response, which were most pronounced in health care workers with a history of severe or moderate-to-severe COVID-19, and an association of these changes with certain clinical signs of post-COVID-19 syndrome.

Indexed as

COVID-19Health PersonnelImmunity, MucosalAdultAntibodies, ViralHumansImmunoglobulin AImmunoglobulin GMiddle AgedRespiratory SystemRussiaSARS-CoV-2Severity of Illness IndexYoung AdultAntibodies, ViralImmunoglobulin AImmunoglobulin G

Identifiers

PMID37138005
PMCPMC10154756
OpenAlexW4368362003

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.